Modulatory effects of human donor bone marrow cells on allogeneic cellular immune responses

Transplantation

Volumn 63, Issue 5, 1997, Pages 686-692

  Mathew, James M ^a   Carreno, Manuel ^a   Fuller, Laphalle ^a   Ricordi, Camillo ^a   Tzakis, Andreas ^a   Esquenazi, Violet ^a   Miller, Joshua ^a,b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; BONE MARROW CELL; CELL MEDIATED LYMPHOLYSIS; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; GRAFT SURVIVAL; HUMAN; HUMAN CELL; IMMUNOMODULATION; MIXED LYMPHOCYTE CULTURE; PRIORITY JOURNAL; RECIPIENT; SPLEEN CELL;

BONE MARROW; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; CELL ADHESION; DOWN-REGULATION; HUMANS; IMMUNITY, CELLULAR; KINETICS;

EID: 0030893515     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199703150-00013     Document Type: Article

References (42)

1. Billingham RE, Brent L, Medawar PB. "Actively acquired tolerance" of foreign cells. Nature 1953; 172: 603.
2. Opelz G, Terasaki PI. Improvement of kidney-graft survival with increased numbers of blood transfusions. N Engl J Med 1978; 299: 799.
3. Salvatierra O Jr, Vincenti F, Amend W, et al. Deliberate donor-specific blood transfusions prior to living related renal transplantation. Ann Surg 1978; 192; 543.
4. Monaco AP, Wood ML. Studies on heterologous antilymphocyte serum in mice: VII. Optimal cellular antigen for induction of immunologic tolerance with ALS. Transplant Proc 1970; 2: 489.
5. Caridis DT, Liegeois A, Barrett I, Monaco AP. Enhanced survival of canine renal allografts of ALS-treated dogs given bone marrow. Transplant Proc 1973; 5: 671.
6. Hartner WC, DeFazio SR, Maki T, Markees TG, Monaco AP, Gozzo JJ. Prolongation of renal allograft survival in antilymphocyte-serum-treated dogs by postoperative injection of density-gradient-fractionated donor bone marrow. Transplantation 1986; 42: 593.
7. Thomas JM, Carver FM, Foil MB. Renal allograft tolerance induced with ATG and donor bone marrow in outbred rhesus monkeys. Transplantation 1983; 36: 104.
8. Thomas JM, Verbanac KM, Thomas FT. The veto mechanism in transplant tolerance. Transplant Rev 1991; 5: 209.
9. Barber HW, Mankin JA, Laskow DA, et al. Long-term results of a controlled prospective study with transfusion of donor-specific bone marrow in 57 cadaveric renal allograft recipients. Transplantation 1991; 51: 70.
10. Starzl TE, Demetris AJ, Trucco M, et al. Cell migration and chimerism after whole organ transplantation: the basis of graft acceptance. Hepatology 1993; 17: 1127.
11. Starzl TE, Demetris AJ, Trucco M, et al. Chimerism and donor specific nonreactivity 27 to 29 years after kidney allotransplantation. Transplantation 1993; 55: 1272.
12. Mathew JM, Marsh JW, Susskind B, Mohanakurnar T. Analysis of T cell responses in liver allograft recipients: evidence for deletion of donor-specific cytotoxic T cells in the peripheral circulation. J Clin Invest 1993; 91: 900.
13. Kamada N, Shinomiya T. Clonal deletion as the mechanism of abrogation of immunological memory following liver grafting in rats. Immunology 1985; 55: 85.
14. Martin DR, Miller RG. In vivo administration of histoincompatible lymphocytes leads to rapid functional deletion of cytotoxic T lymphocyte precursors. J Exp Med 1989; 170: 679.
15. Palathumpat V, Dejbakhsh-Jones S, Holm B, Wang H, Liang O, Strober S. Studies of CD4- CDS- αβ bone marrow T cells with suppressor activity. J Immunol 1992; 148: 373.
16. Alters SE, Shizuru JA, Ackerman J, Grossman D, Seydel KB, Fathman CG. Anti-CD4 mediates clonal anergy during transplantation tolerance induction. J Exp Med 1991; 173: 491.
17. Muraoka S, Miller RG. Cells in bone marrow and in T cell colonies grown from bone marrow can suppress generation of cytotoxic T lymphocytes directed against their self antigens. J Exp Med 1980; 152: 54.
18. Schwadron RB, Candour DM, Strober S. Cloned natural suppressor cell lines derived from the spleens of neonatal mice. J Exp Med 1985; 162: 297.
19. Halwani F, Guttmann RD, Sainte Croix H, Prudhomme GJ. Identification of natural suppressor cells in long-term renal allograft recipients. Transplantation 1992; 54: 973.
20. Dallman MJ, Shiho O, Page TH, Wood KJ, Morris PJ. Peripheral tolerance to alloantigen results from altered regulation of the interleukin 2 pathway. J Exp Med 1991; 173: 79.
21. Hertel-Wulff B, Strober S. Immunosuppressive lymphokine derived from natural suppressor cells. J Immunol 1988; 140: 2633.
22. Ricordi C, Karatzas T, Selvaggi G, et al. Multiple bone marrow infusions to enhance acceptance of allografts from the same donor. Ann NY Acad Sci 1995; 770: 345.
23. Kaplan ME, Clark C. An improved rosetting assay for detection of human T lymphocytes. J Immunol Methods 1974; 5: 131.
24. Carreno M, Miller J, Esquenazi V, Milgrom M, Roth D, Fuller L. Are OKT3 binding sites on T cells modulated or merely converted (blindfolded) by OKT3 during therapy? Transplant Proc 1989; 21: 987.
25. Mathew JM, Shenoy S, Phelan D, Howard T, Mohanakumar T. Biochemical and immunological evaluation of donor specific soluble HLA in the circulation of liver transplant recipients. Transplantation 1996; 62: 217.
26. Strober S, Palathumpat V, Schwadron R, Hertel-Wulff B. Cloned natural suppressor cells prevent lethal graft-vs-host disease. J Immunol 1987; 138: 699.
27. Sugiura K, Ikehara S, Inaba M, et al. Enrichment of murine bone marrow natural suppressor activity in the fraction of hematopoietic progenitors with interleukin 3 receptor-associated antigen. Exp Hematol 1992; 20: 256.
28. Thomas J, Carver M, Cunningham P, Park K, Gonder J. Promotion of incompatible allograft acceptance in rhesus monkeys given post-transplant antithymocyte globulin and donor bone marrow: I. In vivo parameters and immunohistologic evidence suggesting microchimerism. Transplantation 1987; 43: 332.
29. Sykes M, Sachs DH. Mixed allogeneic chimerism as an approach to transplantation tolerance. Immunol Today 1988; 9: 23.
30. Garcia-Morales R, Esquenazi V, Zucker K, et al. Assessment of the effects of cadaver donor bone marrow on kidney allograft recipient blood cell chimerism by a novel technique combining PCR and flow cytometry (PCR-Flow). Transplantation 1996; 62: 1.
31. Burlingham WJ, Grailer AP, Fechner JH Jr, et al. Microchimerism linked to cytotoxic T lymphocyte functional unresponsiveness (clonal anergy) in a tolerant renal transplant recipient. Transplantation 1995; 59: 1147.
32. Gozzo JJ, Crowley M, Maki T, Monaco AP. Functional characteristics of a Ficoll-separated mouse bone marrow cell population involved in skin allograft prolongation. J Immunol 1982; 129: 1584.
33. Thomas JM, Carver FM, Cunningham PRG, Olson LC, Thomas FT. Kidney allograft tolerance in primates without chronic immunosuppression - the role of veto cells. Transplantation 1991; 51: 198.
34. Comoli P, Montagna D, Moretta A, Zecca M, Locatelli F, Maccario R. Alloantigen-induced human lymphocytes rendered nonresponsive by a combination of anti-CD80 monoclonal antibodies and cyclosporin-A suppress mixed lymphocyte reaction in vitro. J Immunol 1995; 155: 5506.
35. Strober S. Natural suppressor (NS) cells, neonatal tolerance, and total lymphoid irradiation: exploring obscure relationships. Annu Rev Immunol 1984; 1: 219.
36. Angulo I, Rodriguez R, García B, Medina M, Navarro J, Subiza JL. Involvement of nitric oxide in bone marrow-derived natural suppressor activity: its dependence on IFN-γ. J Immunol 1995; 155: 15.
37. Schwadren RB, Palathumpat V, Strober S. Natural suppressor cells derived from adult spleen and thymus. Transplantation 1989; 48: 107.
38. Schmidt-Wolf IGH, Dejbakhsh-Jones S, Ginzton N, Greenberg P, Strober S. T-cell subsets and suppressor cells in human bone marrow. Blood 1992; 80: 3242.
39. Kiziroglu F, Miller RG. In vivo functional clonal deletion of recipient CD4+ T helper precursor cells that can recognize class II MHC on injected donor lymphoid cells. J Immunol 1991; 146: 1104.
40. Thomas JM, Carver FM, Kasten-Jolly J, et al. Further studies of veto activity in rhesus monkey bone marrow in relation to allograft tolerance and chimerism. Transplantation 1994; 57: 101.
41. Mueller DL, Jenkins MK. Molecular mechanisms underlying functional T cell unresponsiveness. Curr Opin Immunol 1995; 7: 375.
42. 2+ and protein kinase C-independent lethal signaling pathway. J Immunol 1992; 148: 2996.